David T Broome, MD
Clinical Assistant Professor of Internal Medicine
24 Frank Lloyd Wright Dr., Lobby C, Suite 1300
Ann Arbor
Michigan, 48105
[email protected]

Available to mentor

David T Broome, MD
Clinical Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
  • About

    David T. Broome, MD, is a Clinical Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes (MEND) Division of the University of Michigan. Dr. Broome's clinical and research interests are in Type 1 Diabetes Mellitus, Atypical Diabetes and Monogenic Diabetes (including MODY), Type 2 Diabetes Mellitus. Dr. Broome is dedicated to progress in scholarly work, translational research, and was the recipient of the Tait Endowed Research Scholarship for his work in diabetes in medical school, selected to the Clinical Scholars Program in residency, and several research and teaching awards thereafter, including: the Cleveland Clinic Foundation Endocrinology & Metabolism Institute Research Award, ENDO Experience Travel Award, the Cleveland Clinic Lerner College of Medicine Excellence in Teaching Award, the AACE Domestic Resident Travel Grant, the Michigan Clinical Trials Academy and the Caswell Diabetes Institute Clinical and Translational Scholars Program. Dr. Broome is currently the principal investigator of University of Michigan’s MODY Registry, in addition to the Type 1 Diabetes Exchange. He serves as a Review Editor on the editorial board for Frontiers in Clinical Diabetes and Healthcare and serves on the Editorial Board for the Journal of Clinical Endocrinology & Metabolism (JCEM). In his free time, Dr. Broome enjoys ice hockey, cycling, and spending time with family and friends on the beach in Holland, MI.

    Qualifications
    • Endocrinology Fellow
      Cleveland Clinic Foundation, United States, 2021
    • Internal Medicine Resident
      Cleveland Clinic Foundation, Cleveland, 2019
    • MD
      Wayne State University, Detroit, 2016
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Recent Publications See All Publications
    • Journal Article
      Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY.
      Broome DT, Mehdi A, Chase C, de Freitas MF, Gregg BE, Oral EA, Herman WH. Diabetes Care, 2024 Sep 1; 47 (9): e65 - e66. DOI:10.2337/dc24-0730
      PMID: 39008714
    • Presentation
      MODY: Past, Present & Future
      Broome, MD DT. 2024 Jun 18;
    • Presentation
      Division of Metabolism, Endocrinology and Diabetes (MEND) Fellows’ Lecture: “Atypical Diabetes”
      Broome, MD DT. 2024 Feb 29;
    • Journal Article
      A Novel Receivership Model for Transition of Young Adults With Diabetes: Experience From a Single-center Academic Transition Program.
      Iyengar JJ, Ang L, Rodeman KB, Rao A, Lin YK, Broome DT, Fanous N, Reinert RB, Konigsberg A, Weatherup E, Hagar C, Rogosch D, Florek J, Carey B, Wyckoff J, Lee J, Thomas IH, Soleimanpour SA. Endocr Pract, 2024 Feb; 30 (2): 113 - 121. DOI:10.1016/j.eprac.2023.11.008
      PMID: 38029926
    • Journal Article
      Efficacy and Safety of Glucagon-Like Peptide 1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy.
      Foss-Freitas MC, Imam S, Neidert A, Gomes AD, Broome DT, Oral EA. Diabetes Care, 2024 Apr 1; 47 (4): 653 - 659. DOI:10.2337/dc23-1614
      PMID: 38300898
    • Chapter
      Type 1 Diabetes Mellitus: In the 5-Minute Clinical Consult.
      Broome D, San Martin Montenegro V. 2024 Jan 1; The 5-Minute Clinical Consult 2024,
    • Chapter
      Type 1 Diabetes Mellitus: In the 5-Minute Clinical Consult.
      Broome D, San Martin Montenegro V. 2024 Jan 1; The 5-Minute Clinical Consult 2024,
    • Journal Article
      Performance of Afirma Genomic Sequencing Classifier and Histopathological Outcome in Bethesda Category III Thyroid Nodules: Initial Versus Repeat Fine Needle Aspiration
      Jin X, Lew M, Pantanowitz L, Iyengar J, Haymart M, Papaleontiou M, Broome D, Sandouk Z, Raja S, Hughes D, Smola B, Jing X. Diagnostic Cytopathology, 2023 Jul 31; DOI:10.1002/dc.25203